Healthcare Triangle is trading 17.23% down at $0.60 after Nasdaq’s October 1 delisting determination over its failure to meet the $1 minimum bid-price requirement. - Prior reverse splits make it ineligible for a standard compliance period. - Without an appeal by October 8, trading could be suspended October 12. - The October 2 preliminary proxy seeks approval for a reverse split and potential financing; no October 5 pre-market explanation was identified. Broader indexes were modest and mixed.